Vestmark Advisory Solutions Inc. Has $6.72 Million Position in CorVel Corp. (NASDAQ:CRVL)

Vestmark Advisory Solutions Inc. increased its position in shares of CorVel Corp. (NASDAQ:CRVL) by 92.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 60,026 shares of the business services provider’s stock after purchasing an additional 28,883 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in CorVel were worth $6,721,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in CorVel during the 1st quarter worth approximately $25,000. LGT Financial Advisors LLC raised its holdings in CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock valued at $28,000 after acquiring an additional 170 shares in the last quarter. von Borstel & Associates Inc. acquired a new position in CorVel in the 1st quarter valued at $28,000. Bessemer Group Inc. raised its holdings in CorVel by 6,350.0% in the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock valued at $29,000 after acquiring an additional 254 shares in the last quarter. Finally, Federated Hermes Inc. raised its holdings in CorVel by 154.9% in the 4th quarter. Federated Hermes Inc. now owns 492 shares of the business services provider’s stock valued at $55,000 after acquiring an additional 299 shares in the last quarter. 51.36% of the stock is owned by institutional investors and hedge funds.

CorVel Price Performance

Shares of NASDAQ CRVL opened at $88.41 on Friday. The stock has a market capitalization of $4.54 billion, a PE ratio of 45.57 and a beta of 0.95. The business has a fifty day moving average price of $97.17 and a two-hundred day moving average price of $107.01. CorVel Corp. has a fifty-two week low of $85.13 and a fifty-two week high of $128.61.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings data on Tuesday, August 5th. The business services provider reported $0.52 earnings per share for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

Insider Activity at CorVel

In other news, Director Alan Hoops sold 3,000 shares of the business’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $113.05, for a total transaction of $339,150.00. Following the completion of the transaction, the director owned 16,688 shares of the company’s stock, valued at approximately $1,886,578.40. The trade was a 15.24% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Brandon O’brien sold 3,957 shares of the business’s stock in a transaction on Monday, June 9th. The stock was sold at an average price of $108.46, for a total value of $429,176.22. Following the transaction, the chief financial officer directly owned 11,804 shares of the company’s stock, valued at $1,280,261.84. This trade represents a 25.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,079 shares of company stock worth $1,446,023 in the last three months. Insiders own 44.56% of the company’s stock.

Analysts Set New Price Targets

Separately, Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a report on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.